Suboptimal effect of different vitamin D3 supplementations and doses adapted to baseline serum 25(OH)D on achieved 25(OH)D levels in patients with a recent fracture: A prospective observational study

European Journal of Endocrinology

Volumn 169, Issue 5, 2013, Pages 597-604

  Shab Bidar, Sakineh ^a   Bours, Sandrine P G ^b   Geusens, Piet P M M ^b,c   Van Der Velde, Robert Y ^d   Janssen, Marcel J W ^e   Van Den Bergh, Joop P W ^b,c,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HASSELT UNIVERSITY   (Belgium)

^d VieCuri MC Noord Limburg ^*  (Netherlands)

^e Laboratory for Clinical Chemistry   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID PLUS COLECALCIFEROL; CALCIUM; COLECALCIFEROL;

ADULT; ARTICLE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG INTERMITTENT THERAPY; FEMALE; FOLLOW UP; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINE FRACTURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRACTURES, BONE; HORMONES; HUMANS; HYDROXYCHOLECALCIFEROLS; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMINS;

EID: 84885109203     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0068     Document Type: Article

References (35)

1. Dawson-Hughes B, Heaney RP, Holick MF, Lips P Meunier PJ & Vieth R. Estimates of optimal vitamin D status. Osteoporosis International 2005 16 713-716. (doi:10.1007/s00198-005-1867-7)
2. Findlay M, Anderson J, Roberts S, Almond A & Isles C. Treatment of vitamin D deficiency: divergence between clinical practice and expert advice. Postgraduate Medical Journal 2012 88 255-260. (doi:10.1136/postgradmedj-2011- 130243)
3. Norman AW, Bouillon R, Whiting SJ, Veith R & Lips P. 13 th Workshop consensus for vitamin D nutritional guidelines. Journal of Steroid Biochemistry and Molecular Biology 2007 103 204. (doi:10.1016/j.jsbmb.2006.12.071)
4. Zhao LJ, Zhou Y, Bu F, Travers-Gustafson D, Ye A, Xu X, Hamm L, Gorsage DM, Fang X, Deng HW et al. Factors predicting vitamin D response variation in non-Hispanic white postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2012 97 2699-2705. (doi:10.1210/jc.2011-3401)
5. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA et al. A pooled analysis of vitamin D dose requirements for fracture prevention. New England Journal of Medicine 2012 367 40-49. (doi:10.1056/NEJMoa1109617)
6. Gallagher JC, Sai A, Templin T II & Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Annals of Internal Medicine 2012 156 425-437. (doi:10.7326/0003-4819-156-6-201203200- 00005)
7. Nelson ML, Blum JM, Hollis BW, Rosen C & Sullivan SS. Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausaI women in winter. Journal of Nutrition 2009 139 540-546. (doi:10.3945/jn. 108.096180)
8. Center JR, BIiuc D, Nguyen TV & Eisman JA. Risk of subsequent fracture after Iow-trauma fracture in men and women. Journal of the American Medical Association 2007 297 387-394. (doi:10. 1001/jama.297.4.387)
9. Geusens PP, Lems WF, Verhaar HJ, Leusink G, Goemaere S, Zmierczack H & Compston J. Review and evaIuation of the Dutch guideIines for osteoporosis. Journal of Evaluation in Clinical Practice 2006 12 539-548. (doi:10.1111/j.1365-2753.2006.00647.x)
10. Prevention and managementof osteoporosis. World Health Organization Technical Report Series 2003 921 1-164.
11. Janssen MJ, WieIders JP, Bekker CC, Boesten LS, Buijs MM, Heijboer AC, van der Horst FA, Loupatty FJ & van den OuweIand JM. MuIticenter comparison study of current methods to measure 25-hydroxyvitamin D in serum. Steroids 2012 77 1366-1372. (doi:10.1016/j.steroids.2012.07.013)
12. Levey AS, Coresh J, BaIk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G et al. NationaI Kidney Foundation practice guideIines for chronic kidney disease: evaIuation, cIassi-fication, and stratification. Annals of Internal Medicine 2003 139 137-147. (doi:10.7326/0003-4819-139-2-200307150-00013)
13. BiIezikian JP, Potts JT Jr, FuIeihan GeI H, KIeerekoper M, Neer R, Peacock M, Rastad J, SiIverberg SJ, UdeIsman R & WeIIs SA. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. Journal of Clinical Endocrinology and Metabolism 2002 87 5353-5361. (doi:10.1210/jc.2002-0213 70)
14. BiIezikian J, Khan A, Potts J Jr & on behaIf of the Third InternationaI Workshop on the Management of Asymptomatic Primary Hyperthyroidism. GuideIines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third InternationaI Workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 335-339. (doi:10.1210/jc.2008-1763)
15. Wang C, NieschIag E, SwerdIoff R, Behre HM, HeIIstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, LunenfeId B, MoraIes A et al. Investigation, treatment and monitoring of Iate-onset hypogonadism in maIes: ISA, ISSAM, EAU, EAA and ASA recommendations. European Journal of Endocrinology 2008 159 507-514. (doi:10. 1530/EJE-08-0601)
16. Heaney RP, Davies KM, Chen TC, HoIick MF & Barger-Lux MJ. Human serum 25-hydroxychoIecaIciferoIresponse to extended oraI dosing with choIecaIciferoI. American Journal of Clinical Nutrition 2003 77 204-210.
17. Sneve M, Figenschau Y & Jorde R. SuppIementation with choIecaIciferoI does not resuIt in weight reduction in overweight and obese subjects. European Journal of Endocrinology 2008 159 675-684. (doi:10.1530/EJE-08-0339)
18. Jorde R, Sneve M, Torjesen P, Figenschau Y & Hansen JB. Parameters of the thrombogram are associated with serum 25-hydroxyvitamin D IeveIs at baseIine, but not affected during suppIementation with vitamin D. Thrombosis Research 2010 125 e210-e213. (doi:10.1016/j.thromres.2009.12.011)
19. Seamans KM, HiII TR, WaIIace JM, Horigan G, Lucey AJ, Barnes MS, TayIor N, Bonham MP, MuIdowney S, Duffy EM et al. ChoIecaIciferoI suppIementation throughout winter does not affect markers ofbone turnover in heaIthy young and eIderIy aduIts. Journal of Nutrition 2010 140 454-460. (doi:10.3945/jn. 109.113480)
20. Lips P, Duong T, OIeksik A, BIack D, Cummings S, Cox D & NickeIsen T. A gIobaI study of vitamin D status and parathyroid function in postmenopausaI women with osteoporosis: baseIine data from the muItipIe outcomes of raIoxifene evaIuation cIinicaI triaI. Journal of Clinical Endocrinology and Metabolism 2001 86 1212-1221. (doi:10.1210/jc.86.3.1212)
21. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM & Lips P. Prevention of bone Ioss by vitamin D suppIementation in eIderIy women: a randomized doubIe-bIind triaI. Journal of Clinical Endocrinology and Metabolism 1995 80 1052-1058. (doi:10.1210/jc.80.4.1052)
22. Close GL, Leckey J, Patterson M, Bradley W, Owens DJ, Fraser WD & Morton JP. The effects of vitamin D3 supplementation on serum total 25[OH]D concentration and physical performance: a randomised dose-response study. British Journal of Sports Medicine 2013 47 692-696. (doi:10.1136/bjsports-2012- 091735)
23. Leslie WD & Schousboe JT. A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world. Current Osteoporosis Reports 2011 9 129-140. (doi:10.1007/s11914-011- 0060-5)
24. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS et al. IOM committee members respond to Endocrine Society vitamin D guideline. Journal of Clinical Endocrinology and Metabolism 2012 97 1146-1152. (doi:10.1210/jc.2011-2218)
25. Pietras SM, Obayan BK, Cai MH & Holick MF Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Archives of Internal Medicine 2009 169 1806-1818. (doi:10.1001/archinternmed.2009.361)
26. Netelenbos JC, Geusens PP, Ypma G & Buijs SJ. Adherence and profile of non-persistence in patients treated for osteoporosis - a large-scale, long-term retrospective study in The Netherlands. Osteoporosis International 2011 22 1537-1546. (doi:10.1007/s00198-010-13 72-5)
27. Vogelsang H, Schöll R, Tillinger W, Ferenci P & Gangl A. 25-Hydroxyvitamin D absorption in patients with Chron's disease and with pancreatic insufficiency. Wiener Klinische Wochenschrift 1997 109 678-682.
28. Leblanc ES, Perrin N, Johnson JD, Ballatore A & Hillier T. Over-the-counter and compounded vitamin D: is potency what we expect? Journal of the American Medical Association 2013 173 585-586.
29. Neyestani TR, Djazayery A, Shab-Bidar S, Eshraghian MR, Kalayi A, Shariatzadeh N, Khalaji N, Zahedirad M, Gharavi A, Houshiarrad A et al. Vitamin D receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care 2012 36 550-556. (doi:10. 2337/dc12-0919)
30. Elnenaei MO, Chandra R, Mangion T & Moniz C. Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation. British Journal of Nutrition 2011 105 71-79. (doi:10.1017/S0007114510003065)
31. Fu L, Yun F, Oczak M, Wong BY, Vieth R & Cole DE. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25 (OH) D] to vitamin D supplementation. Clinical Biochemistry 2009 42 1174-1177. (doi:10.1016/j.clinbiochem.2009.03.008)
32. Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1a-hydroxy-lase in the classical and nonclassical actions of 1a, 25-dihydroxy-vitamin D (3). Seminars in Dialysis 2007 20 316-324. (doi:10. 1111/j.1525-139X.2007.00302.x)
33. Holick MF & Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. American Journal of Clinical Nutrition 2008 87 1080S-1086S.
34. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Gharavi A, Kalayi A, Shariatzadeh N, Zahedirad M, Khalaji N et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Medicine 2011 9 125. (doi:10.1186/1741-7015-9-125)
35. van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ & Lips P. Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. American Journal of Clinical Nutrition 2007 85 755-761.